Celestoderm-V Ointment 0.1% 15g
Corticosteroids for dermatological use. Active corticosteroids (group iii). Betamethasone. ATX code D07A C01.
active substance: betamethasone;
1 g of ointment contains betamethasone 17-valerate is equivalent to 1 mg of betamethasone;
excipients: white soft paraffin, mineral oil.
Local treatment of dermatitis, especially allergic dermatitis, toxic eczema, atopic dermatitis and psoriasis.
- hypersensitivity to active substances or to any of the excipients specified in the “Composition” section;
- acne vulgaris;
- generalized plaque psoriasis;
- perioral dermatitis;
- viral skin infections such as herpes simplex or chickenpox;
- skin lesions caused by a fungal or bacterial infection, in the absence of appropriate therapy for the infection.
- It is not recommended to use Celestoderm-B ointment under occlusive dressings (gypsum, etc.).
Adult patients, incl. elderly patients Apply
1-3 times a day. The frequency of application is determined depending on the severity of the disease. In case of diseases of mild severity, application once a day is sufficient, while in severe forms of the disease, it is necessary to apply it 3 times a day.
There are no data on the use of the drug Celestoderm-B in patients with renal or hepatic insufficiency.
For cutaneous use. Apply in a thin layer to the affected skin.
If irritation or signs of hypersensitivity occur when using the drug Celestoderm-B, treatment should be discontinued and appropriate therapy should be prescribed.
With the use of systemic and local corticosteroids, including intranasal, inhalation and ophthalmic use, visual impairment is possible. If symptoms such as blurred vision or other visual impairments occur, the patient should be examined by an ophthalmologist to assess possible causes of visual impairment, which may include cataracts, glaucoma, or rare conditions such as central serous chorioretinopathy, as reported after systemic and local action.
Since the ratio of surface area to body weight in children is greater than in adults, the degree of inhibition of the function of the hypothalamic-pituitary-adrenal system (HPAI) by local corticosteroids is higher in children than in adults.
Store in a dark place and out of reach of children at a temperature not exceeding 25 ºС
Produced in Belgium